Submitted by Anonymous (not verified) on 20 September 2023 - 14:41
Human medicines European public assessment report (EPAR): Vizamyl, flutemetamol (18F), Radionuclide Imaging;Alzheimer Disease, Date of authorisation: 22/08/2014, Revision: 16, Status: Authorised
Source: